- Home
- AIRG vs ASRT Comparison
AIRG vs ASRT Comparison
Compare AIRG & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRG
- ASRT
- Stock Information
- Founded
- AIRG 1995
- ASRT 1995
- Country
- AIRG United States
- ASRT United States
- Employees
- AIRG N/A
- ASRT N/A
- Industry
- AIRG Radio And Television Broadcasting And Communications Equipment
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- AIRG Technology
- ASRT Health Care
- Exchange
- AIRG Nasdaq
- ASRT Nasdaq
- Market Cap
- AIRG 48.7M
- ASRT 57.9M
- IPO Year
- AIRG 2016
- ASRT 1997
- Fundamental
- Price
- AIRG $4.00
- ASRT $0.66
- Analyst Decision
- AIRG Strong Buy
- ASRT Strong Buy
- Analyst Count
- AIRG 2
- ASRT 3
- Target Price
- AIRG $9.25
- ASRT $3.08
- AVG Volume (30 Days)
- AIRG 11.7K
- ASRT 284.6K
- Earning Date
- AIRG 05-07-2025
- ASRT 05-12-2025
- Dividend Yield
- AIRG N/A
- ASRT N/A
- EPS Growth
- AIRG N/A
- ASRT N/A
- EPS
- AIRG N/A
- ASRT N/A
- Revenue
- AIRG $58,381,000.00
- ASRT $119,001,000.00
- Revenue This Year
- AIRG N/A
- ASRT N/A
- Revenue Next Year
- AIRG $23.54
- ASRT $11.71
- P/E Ratio
- AIRG N/A
- ASRT N/A
- Revenue Growth
- AIRG 8.46
- ASRT N/A
- 52 Week Low
- AIRG $3.17
- ASRT $0.51
- 52 Week High
- AIRG $10.34
- ASRT $1.80
- Technical
- Relative Strength Index (RSI)
- AIRG 48.84
- ASRT 50.57
- Support Level
- AIRG $4.00
- ASRT $0.67
- Resistance Level
- AIRG $4.35
- ASRT $0.71
- Average True Range (ATR)
- AIRG 0.21
- ASRT 0.04
- MACD
- AIRG 0.00
- ASRT 0.00
- Stochastic Oscillator
- AIRG 34.99
- ASRT 52.69
About AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.